Ad is loading...
ALID
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
ARSUF
Price
$20.03
Change
-$0.00 (-0.00%)
Updated
Oct 29 closing price
Ad is loading...

ALID vs ARSUF

Header iconALID vs ARSUF Comparison
Open Charts ALID vs ARSUFBanner chart's image
Allied
Price$0.05
Change-$0.00 (-0.00%)
Volume$10.45K
CapitalizationN/A
Fagron SA
Price$20.03
Change-$0.00 (-0.00%)
Volume$425
CapitalizationN/A
ALID vs ARSUF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ALID vs. ARSUF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALID is a Hold and ARSUF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ALID: $0.05 vs. ARSUF: $20.03)
Brand notoriety: ALID and ARSUF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALID: 149% vs. ARSUF: 65%
Market capitalization -- ALID: $25.18M vs. ARSUF: $1.27B
ALID [@Pharmaceuticals: Other] is valued at $25.18M. ARSUF’s [@Pharmaceuticals: Other] market capitalization is $1.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALID’s FA Score shows that 0 FA rating(s) are green whileARSUF’s FA Score has 1 green FA rating(s).

  • ALID’s FA Score: 0 green, 5 red.
  • ARSUF’s FA Score: 1 green, 4 red.
According to our system of comparison, ARSUF is a better buy in the long-term than ALID.

Price Growth

ALID (@Pharmaceuticals: Other) experienced а +0.97% price change this week, while ARSUF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
ARSUF($1.27B) has a higher market cap than ALID($25.2M). ARSUF YTD gains are higher at: 8.391 vs. ALID (-40.606). ARSUF has higher annual earnings (EBITDA): 136M vs. ALID (-5.4M). ARSUF has more cash in the bank: 119M vs. ALID (165K). ALID has less debt than ARSUF: ALID (5.67M) vs ARSUF (385M). ARSUF has higher revenues than ALID: ARSUF (727M) vs ALID (193K).
ALIDARSUFALID / ARSUF
Capitalization25.2M1.27B2%
EBITDA-5.4M136M-4%
Gain YTD-40.6068.391-484%
P/E RatioN/A17.83-
Revenue193K727M0%
Total Cash165K119M0%
Total Debt5.67M385M1%
FUNDAMENTALS RATINGS
ARSUF: Fundamental Ratings
ARSUF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FXE97.180.08
+0.08%
Invesco CurrencyShares® Euro Currency
PULS49.680.01
+0.02%
PGIM Ultra Short Bond ETF
MSTI20.48-0.01
-0.05%
Madison Short-Term Strategic Income ETF
OUSA53.90-0.44
-0.81%
ALPS O'Shares US Quality Div ETF
QTAP36.68-0.44
-1.20%
Innovator Growth-100 Acltd Ps ETF™ April

ALID and

Correlation & Price change

A.I.dvisor tells us that ALID and ABSCF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALID and ABSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALID
1D Price
Change %
ALID100%
+0.97%
ABSCF - ALID
16%
Poorly correlated
N/A
ARSUF - ALID
8%
Poorly correlated
N/A
APNHY - ALID
6%
Poorly correlated
N/A
YCBD - ALID
4%
Poorly correlated
-3.83%
ORGO - ALID
2%
Poorly correlated
-3.62%
More

ARSUF and

Correlation & Price change

A.I.dvisor tells us that ARSUF and CRDL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
CRDL - ARSUF
22%
Poorly correlated
-2.15%
AVCNF - ARSUF
12%
Poorly correlated
-0.94%
ALID - ARSUF
8%
Poorly correlated
+0.97%
BMMJ - ARSUF
3%
Poorly correlated
-24.07%
BSPK - ARSUF
2%
Poorly correlated
-27.31%
More